Personal Genome Services Market Forecast Highlights Expansion From $7.85 Billion To $13.69 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Personal Genome Services Market CAGR Analysis And Future Market Development
The personal genome services market has experienced rapid growth in recent years. It is anticipated to expand from $6.84 billion in 2025 to $7.85 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.7%. Historically, this market’s expansion can be attributed to several factors: declining sequencing costs, an increase in ancestry testing demand, a rise in consumer genetics awareness, the proliferation of genomics startups, and enhanced sequencing accuracy.
The personal genome services market is projected for significant expansion in the coming years. This market is set to reach $13.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. Factors driving this growth during the forecast period include the increasing adoption of preventive genomics, wider use of pharmacogenomics, growing consumer demand for personalized wellness, more extensive insurance coverage for testing, and the integration of these services with digital health platforms. Key trends anticipated for this period encompass direct-to-consumer genome testing, comprehensive health risk genomic reports, bundled pharmacogenomic services, preventive genome screening packages, and digital platforms for genetic counseling.
Download A Free Sample Report For Comprehensive Market Insights:
Personal Genome Services Market Demand Drivers: What Is Fueling Industry Growth?
A heightened focus on personalized medicine is projected to propel the expansion of the personal genome services market moving forward. This medical approach customizes treatment and prevention strategies based on an individual’s genetic, biological, and lifestyle characteristics. The adoption of personalized medicine is escalating due to progress in genomics and molecular diagnostics, which enable treatments to be tailored to an individual’s genetic profile for superior outcomes. Personal genome services support personalized medicine by analyzing an individual’s genetic makeup to forecast disease risk, inform drug selection, and customize prevention and treatment approaches. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, marking an increase from six in 2022. The newly approved personalized treatments for 2023 further included seven cancer drugs and three for other diseases and conditions. As a result, the increasing emphasis on personalized medicine is fueling the growth of the personal genome services market.
Personal Genome Services Market Segmentation And Category Breakdown
The personal genome services market covered in this report is segmented –
1) By Service Type: Genetic Testing; Whole Genome Sequencing; Carrier Testing; Ancestry Testing; Other Service Types
2) By Application: Healthcare; Research; Ancestry; Other Applications
3) By End-User: Hospitals and Clinics; Research Centers; Direct-to-Consumer; Other End-Users
Subsegments:
1) By Genetic Testing: Health Risk Assessment Testing; Pharmacogenomic Testing; Nutritional Genetic Testing; Lifestyle Genetic Testing; Wellness Genetic Screening
2) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; Preventive Health Genome Sequencing; Rare Disease Genome Sequencing; Population Based Genome Sequencing
3) By Carrier Testing: Inherited Disease Carrier Screening; Preconception Carrier Testing; Prenatal Carrier Testing; Reproductive Health Carrier Screening; Family Planning Carrier Testing
4) By Ancestry Testing: Ethnicity Estimation Testing; Genealogical Lineage Testing; Migration Pattern Analysis; Regional Ancestry Breakdown; Family Relationship Discovery
5) By Other Service Types: Newborn Genetic Screening; Predictive Genetic Testing; Sports Performance Genetic Analysis; Personalized Health Reporting; Custom Genetic Consulting Services
Personal Genome Services Market Innovation Trends: Which Developments Are Transforming The Industry?
Major companies in the personal genome services market are concentrating on creating sophisticated solutions like genome-wide risk stratification to deliver personalized health insights, forecast disease susceptibility, and guide preventive and lifestyle interventions. Genome-wide risk stratification involves analyzing an individual’s entire genome to identify genetic variations contributing to the risk of developing specific diseases or conditions, thereby enabling customized health risk predictions and targeted preventive strategies. For example, in November 2025, MyOme Inc., a US-based biotechnology company, introduced the first integrated polygenic risk score (iPRS) test for prostate cancer. This test combines approximately 7 million genetic markers with clinical factors to provide personalized 10-year and lifetime risk estimates, validated in 140,000+ diverse men. Its objective is early detection and prevention for 95% of cases without rare variants such as BRCA2, guiding PSA or MRI or biopsies for high-risk individuals (those with 3-4x elevated odds in the top decile) while reducing false positives and overtreatment. The benefits include precise stratification, equitable performance across ancestries, and lifelong AI-updated insights from one whole-genome sample.
Personal Genome Services Market Competitive Analysis Of Major Industry Participants
Major companies operating in the personal genome services market are Thermo Fisher Scientific Inc, Illumina Inc, Helix OpCo LLC, Ancestry.com Operations Inc, Fulgent Genetics Inc, 23andMe Holding Co, Prenetics Global Limited, MyHeritage Ltd, Color Health Inc, Genomics plc, GenoPalate Inc, Living DNA Ltd, Mapmygenome India Pvt Ltd, Nebula Genomics Inc, Xcode Life Sciences Pvt Ltd, Sema4 Holdings Corp, Gene by Gene Ltd, TellmeGen SL, CRI Genetics LLC, African Ancestry Inc, and DNAFit Limited.
Access The Complete Personal Genome Services Market Report:
Personal Genome Services Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the personal genome services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personal genome services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
